肥胖食蟹猴一般身体指标、血糖、血脂的动态监测及相关性分析

doi:10.12300/j.issn.1674-5817.2024.091

实验动物与比较医学 ›› 2025, Vol. 45 ›› Issue (1): 30-36.DOI: 10.12300/j.issn.1674-5817.2024.091

• 实验动物资源开发与利用 • 上一篇下一篇

肥胖食蟹猴一般身体指标、血糖、血脂的动态监测及相关性分析

韦炎冶¹(), 申果¹, 张鹏飞¹^,², 石松平¹, 胡家豪¹, 张绪哲¹, 花慧源³, 花冠洋³, 陆宏正³, 曾勇¹^,⁴, 季风¹^,⁴, 韦祝梅¹^,⁴()()

^1.广西华仁济瀛生物科技有限公司, 南宁 530000
^2.广西科学院, 南宁 530007
^3.来宾市新桂生物科技有限公司, 来宾 546108
^4.广西华仁医学科技集团, 南宁 530000

收稿日期:2024-07-03 修回日期:2024-11-15 出版日期:2025-03-12 发布日期:2025-02-25
通讯作者: 韦祝梅（1978—），女，硕士，兽医师，研究方向：灵长类实验动物疾病模型。E-mail： weizhumei@hrjyswkj.com。ORCID：0000-0002-1846-7501
作者简介:韦炎冶（1994—），女，硕士，助理研究员，研究方向：实验动物代谢相关疾病模型。E-mail： weiyanye@hrjyswkj.com
基金资助:
南宁市良庆区重点科技计划专项“食蟹猴代谢异常疾病模型研究”(202309)

Dynamic Monitoring and Correlation Analysis of General Body Indicators, Blood Glucose, and Blood Lipid in Obese Cynomolgus Monkeys

WEI Yanye¹(), SHEN Guo¹, ZHANG Pengfei¹^,², SHI Songping¹, HU Jiahao¹, ZHANG Xuzhe¹, HUA Huiyuan³, HUA Guanyang³, LU Hongzheng³, ZENG Yong¹^,⁴, JI Feng¹^,⁴, WEI Zhumei¹^,⁴()()

^1.Guangxi Huaren Jiying Biotechnology Co. , Ltd. , Nanning 530000, China
^2.Guangxi Academy of Sciences, Nanning 530007, China
^3.Laibin Xingui Biotechnology Co. , Ltd. , Laibin 546108, China
^4.Guangxi Huaren Medical Science and Technology Group, Nanning 530000, China

Received:2024-07-03 Revised:2024-11-15 Published:2025-02-25 Online:2025-03-12
Contact: WEI Zhumei (ORCID: 0000-0002-1846-7501), E-mail: weizhumei@hrjyswkj.com

摘要/Abstract

摘要：

目的通过检测肥胖型食蟹猴的一般身体指标与血糖、血脂的动态变化，探究各指标之间相关性，为肥胖食蟹猴模型研究提供参考依据。方法选取5～17岁的正常雄性食蟹猴30只（体重指数＜35 kg/m²且糖化血红蛋白含量＜4.50%）和自发性肥胖雄性食蟹猴99只（体重指数≥35 kg/m²且糖化血红蛋白含量＜4.50%），连续3年监测其腹围、皮脂厚度、体重、体重指数、空腹血糖、糖化血红蛋白以及血脂四项指标，并使用重复测量方差分析、简单线性回归和多元线性回归相关性分析方法分析各指标间的相关性。结果与正常食蟹猴相比，肥胖食蟹猴的腹围、皮脂厚度、体重、体重指数和甘油三酯水平均显著升高（均P<0.05）；正常食蟹猴的皮脂厚度逐年上升，其余指标维持稳定。与第1年相比，肥胖食蟹猴第2年腹围、皮脂厚度、体重、体重指数、甘油三酯和空腹血糖水平显著升高（均P<0.05），且升高趋势在第3年持续存在（均P<0.05）。正常食蟹猴第2、3年的肥胖发生率分别为16.67%和23.33%，糖尿病的发病率均为16.67%。肥胖食蟹猴第2、3年糖尿病的发病率分别为29.29%、44.44%，其中在11～13岁群体发病率分别为36.36%、44.68%，大于13岁群体的发病率（分别为28.13%和51.35%）。相关性分析结果显示，糖尿病发病组食蟹猴的空腹血糖与年龄、腹围、皮脂厚度、体重、甘油三酯水平均显著相关（均P<0.05）。结论长期肥胖可导致食蟹猴的一般身体指标及空腹血糖水平升高，并增加糖尿病的发病率；在肥胖引起的糖尿病食蟹猴中，其空腹血糖与年龄、体重、腹围、皮脂厚度、甘油三酯水平均高度相关，这对于预测自发性糖尿病的发生有一定意义。

关键词: 肥胖, 食蟹猴, 身体指标, 血糖, 血脂, 相关性分析

Abstract:

Objective This study aims to investigate the dynamic changes in general body parameters, blood glucose, and blood lipid profiles in obese cynomolgus monkeys, exploring the correlations among these parameters and providing a reference for research on the obese cynomolgus monkey model. Methods 30 normal male cynomolgus monkeys aged 5 - 17 years old (with body mass index < 35 kg/m2 and glycated hemoglobin content < 4.50%) and 99 spontaneously obese male cynomolgus monkeys (with body mass index ≥35 kg/m2 and glycated hemoglobin content < 4.50%) were selected. Over a period of three years, their abdominal circumference, skinfold thickness, body weight, body mass index, fasting blood glucose, glycated hemoglobin, and four blood lipid indicators were monitored. The correlations between each indicator were analyzed using repeated measurement ANOVA, simple linear regression, and multiple linear regression correlation analysis method. Results Compared to the control group, the obese group exhibited significantly higher levels of abdominal circumference, skinfold thickness, body weight, body mass index, and triglyceride (P＜0.05). In the control group, skinfold thickness increased annually, while other indicators remained stable. Compared with the first year, the obese group showed significantly increased abdominal circumference, skinfold thickness, body weight, body mass index, triglyceride, and fasting blood glucose in the second year(P＜0.05), with this increasing trend persisting in the third year (P＜0.05). In the control group, the obesity incidence rates in the second and third years were 16.67% and 23.33%, respectively, while the prevalence of diabetes remained at 16.67%. In the obese group, the diabetes incidence rates were 29.29% and 44.44% in years 2 and 3, respectively. Among the 11-13 year age group, the incidence rates were 36.36% and 44.68%, while for the group older than 13 years, the rates were 28.13% and 51.35%. Correlation analysis revealed significant associations (P＜0.05) between fasting blood glucose and age, abdominal circumference, skinfold thickness, body weight, and triglyceride in the diabetic monkeys. Conclusion Long-term obesity can lead to the increases in general physical indicators and fasting blood glucose levels in cynomolgus monkeys, and an increase in the incidence of diabetes. In diabetic cynomolgus monkeys caused by obesity, there is a high correlation between their fasting blood glucose and age, weight, abdominal circumference, skinfold thickness, and triglyceride levels, which is of some significance for predicting the occurrence of spontaneous diabetes.

Key words: Obesity, Cynomolgus monkey, Body indicator, Blood glucose, Blood lipid, Correlation analysis

中图分类号:

Q95-33

韦炎冶,申果,张鹏飞,等. 肥胖食蟹猴一般身体指标、血糖、血脂的动态监测及相关性分析[J]. 实验动物与比较医学, 2025, 45(1): 30-36. DOI: 10.12300/j.issn.1674-5817.2024.091.

WEI Yanye,SHEN Guo,ZHANG Pengfei,et al. Dynamic Monitoring and Correlation Analysis of General Body Indicators, Blood Glucose, and Blood Lipid in Obese Cynomolgus Monkeys[J]. Laboratory Animal and Comparative Medicine, 2025, 45(1): 30-36. DOI: 10.12300/j.issn.1674-5817.2024.091.

图/表 4

参考文献 17

1	BRANDON A E, LIAO B M, DIAKANASTASIS B, et al. Protein kinase C Epsilon deletion in adipose tissue, but not in liver, improves glucose tolerance[J]. Cell Metab, 2019, 29(1):183-191.e7. DOI: 10.1016/j.cmet.2018.09.013 .
2	李瑞生, 李晓娟, 高蓉, 等. 食蟹猴微卫星DNA标记遗传监测及多态性分析[J]. 中国比较医学杂志, 2011, 21(8):27-30. DOI: 10.3969/j.issn.1671-7856.2011.08.007 .
	LI R S, LI X J, GAO R, et al. Genetic monitoring and polymorphism analysis using microsatellite DNA markers in Macaca fascicularis [J]. Chin J Comp Med, 2011, 21(8):27-30. DOI: 10.3969/j.issn.1671-7856.2011.08.007 .
3	IKEGAMI K, TAGAWA K, NARISAWA S, et al. Suitability of the Cynomolgus monkey as an animal model for drug absorption studies of oral dosage forms from the viewpoint of gastrointestinal physiology[J]. Biol Pharm Bull, 2003, 26(10):1442-1447. DOI: 10.1248/bpb.26.1442 .
4	杨畅. 自发性糖尿病肾病食蟹猴生化与肾脏显微形态学的比较研究[D]. 昆明: 云南大学, 2016.
	YANG C. A comparative study on biochemical criterion and kidney micromorphological characteristics in spontaneous diabetic nephropathy Cynomolgus monkey[D]. Kunming: Yunnan University, 2016.
5	杨永立, 李锋, 汪云龙, 等. 高脂血症食蟹猴模型的建立及分析[J]. 实验动物科学, 2019, 36(4):31-34. DOI: 10.3969/j.issn.1006-6179.2019.04.008 .
	YANG Y L, LI F, WANG Y L, et al. Establishment and analysis of hyperlipidemia model in Cynomolgus monkey[J]. Lab Anim Sci, 2019, 36(4):31-34. DOI: 10.3969/j.issn.1006-6179.2019.04.008 .
6	YU Y J, LI Z C, TIAN J L, et al. Why do people gain belly fat in rural areas? a study of urinary Metal(loid)s and abdominal obesity in China[J]. Environ Sci Technol, 2023, 57(21):7938-7949. DOI: 10.1021/acs.est.2c09464 .
7	IQBAL J, WU H X, HU N, et al. Effect of glucagon-like peptide-1 receptor agonists on body weight in adults with obesity without diabetes mellitus-a systematic review and meta-analysis of randomized control trials[J]. Obes Rev, 2022, 23(6): e13435. DOI: 10.1111/obr.13435 .
8	CONWAY B, RENE A. Obesity as a disease: no lightweight matter[J]. Obes Rev, 2004, 5(3):145-151. DOI: 10.1111/j.1467-789x.2004.00144.x .
9	胡煜琳, 杜晓刚. 血脂水平及血脂异常不同临床分类与糖尿病肾病的相关性及预测价值研究[J]. 四川大学学报(医学版), 2023, 54(5): 1013-1018. DOI: 10.12182/20230960103 .
	HU Y L, DU X G. Blood lipid indicators and different clinical classifications of dyslipidemia and diabetic kidney disease: Correlation and predictive value[J]. J Sichuan Univ (Med Sci), 2023, 54(5): 1013-1018. DOI: 10.12182/20230960103 .
10	POWELL-WILEY T M, POIRIER P, BURKE L E, et al. Obesity and cardiovascular disease: a scientific statement from the American heart association[J]. Circulation, 2021, 143(21): e984-e1010. DOI: 10.1161/CIR.0000000000000973 .
11	张晓英, 韩彦渊. 内脏脂肪组织及其评估指标与糖尿病肾病的研究进展[J]. 临床医学进展, 2023, 13(7): 11594-11600. DOI: 10.12677/ACM.2023.1371622 .
	ZHANG X Y, HAN Y Y. Visceral adipose tissue and its evaluation index and the research progress of diabetic nephropathy[J]. Adv Clin Med, 2023, 13(7): 11594-11600. DOI: 10.12677/ACM.2023.1371622 .
12	ROBBINS S. Ginger supplementation may improve fasting blood glucose, hemoglobin ale, and blood pressure in adults with type 2 diabetes[J]. Herbalgram, 2023(137): 1-2.
13	时黛, 顾雯, 李晓英, 等. 代谢综合征患者血脂、血糖、血压及炎症介质与血清胰岛素生长因子-1的相关性[J]. 贵州医科大学学报, 2023, 48(10):1199-1203. DOI: 10.19367/j.cnki.2096-8388.2023.10.012 .
	SHI D, GU W, LI X Y, et al. Correlation of serum insulin growth factor-1 with blood lipid, blood glucose, blood pressure and inflammatory mediators in patients with metabolic syndrome[J]. J Guizhou Med Univ, 2023, 48(10):1199-1203. DOI: 10.19367/j.cnki.2096-8388.2023.10.012 .
14	SHIFERAW B, TAGESECH Y, ESHETE M A. Dyslipidemia and associated factors among diabetic patients attending Durame General Hospital in Southern Nations, Nationalities, and People's Region[J]. Diabetes Metab Syndr Obes, 2017, 10:265-271. DOI: 10.2147/DMSO.S135064 .
15	张姗姗. 脂质代谢指标与2型糖尿病患者腹部脂肪分布的相关性研究[D]. 长春: 吉林大学, 2023. DOI: 10.27162/d.cnki.gjlin.2023.006556 .
	ZHANG S S. Correlation of lipid metabolic indexes with abdominal fat distribution in patients with type 2 diabetes mellitus[D]. Changchun: Jilin University, 2023. DOI: 10.27162/d.cnki.gjlin.2023.006556 .
16	陈畅. 肥胖症患者非酒精性脂肪肝病临床特征分析及相关危险因素探索[D]. 济南: 山东大学, 2023. DOI: 10.27272/d.cnki.gshdu.2023.006983 .
	CHEN C. Analysis of clinical characteristics of nonalcoholic fatty liverdisease in obese patients and exploration of related risk factors[D]. Jinan: Shandong University, 2023. DOI: 10.27272/d.cnki.gshdu.2023.006983 .
17	CHEN Y, ONO F, YOSHIDA T, et al. Relationship between body weight and hematological and serum biochemical parameters in female Cynomolgus monkeys (Macaca fascicularis)[J]. Exp Anim, 2002, 51(2):125-131. DOI: 10.1538/expanim.51.125 .

指标 Indicator	正常组（N=30） Normal group			肥胖组（N=99） Obese group			F值 F value			P值 P value
指标 Indicator	2022	2023	2024	2022	2023	2024	F_交互^a	F_时间^b	F_组间^c	P_交互^a	P_时间^b	P_组间^c
AC l/cm	37.12±4.27	38.13±5.14	36.93±6.42	46.58±7.35^**	50.03±8.47^**△△	49.77±8.53^**△△	3.487	5.969	67.589	0.032	<0.01	<0.01
SFT d/mm	4.55±2.21	8.30±4.43^△△	8.17±4.82^△△	13.40±9.29^**	18.76±10.14^**△△	22.01±12.82^**△△	3.524	20.057	39.045	0.032	<0.01	<0.01
BW m/kg	6.93±0.91	7.27±0.93	7.30±1.09	9.59±1.81^**	10.50±2.20^**△△	10.60±2.20^**△△	2.893	13.517	70.542	0.059	<0.01	<0.01
BMI	33.13±3.45	34.20±4.67	34.51±5.81	42.88±6.10^**	47.17±8.25^**△△	48.57±0.59^**△△	4.433	12.116	77.520	0.014	<0.01	<0.01
TG c/(mmol·L^-1)	0.63±0.23	0.77±0.34	0.69±0.23	0.75±0.45	1.08±0.67^*△△	0.98±0.49^**△△	1.968	9.659	8.423	0.144	<0.01	0.040
TC c/(mmol·L^-1)	1.86±0.41	2.26±0.42^△△	2.09±0.52	2.07±0.44^**	2.47±0.55^△△	2.10±0.45	4.480	53.847	2.704	0.012	<0.01	0.103
LDL-C c/(mmol·L^-1)	0.97±0.25	0.84±0.27	0.81±0.30	0.96±0.29	0.95±0.36	0.88±0.31^*	1.902	6.624	1.271	0.151	<0.01	0.262
HDL-C c/(mmol·L^-1)	1.69±0.60	2.23±0.69^△△	2.29±0.69^△△	2.07±0.67	2.26±0.77^△	2.06±0.64	7.541	12.433	0.302	0.010	<0.01	0.584
FPG c/(mmol·L^-1)	4.40±0.24	4.52±1.12	4.49±1.58	4.48±1.04	5.25±1.99^△△	5.10±1.83^△△	1.826	3.442	3.524	0.163	0.034	0.063
HbA1c ω/%	4.12±1.34	4.11±0.29	4.10±0.25	4.21±0.19	4.42±0.92^△	4.45±1.45	0.606	0.437	3.502	0.547	0.642	0.064

指标 Indicator	正常组（N=30） Normal group			肥胖组（N=99） Obese group			F值 F value			P值 P value
指标 Indicator	2022	2023	2024	2022	2023	2024	F_交互^a	F_时间^b	F_组间^c	P_交互^a	P_时间^b	P_组间^c
AC l/cm	37.12±4.27	38.13±5.14	36.93±6.42	46.58±7.35^**	50.03±8.47^**△△	49.77±8.53^**△△	3.487	5.969	67.589	0.032	<0.01	<0.01
SFT d/mm	4.55±2.21	8.30±4.43^△△	8.17±4.82^△△	13.40±9.29^**	18.76±10.14^**△△	22.01±12.82^**△△	3.524	20.057	39.045	0.032	<0.01	<0.01
BW m/kg	6.93±0.91	7.27±0.93	7.30±1.09	9.59±1.81^**	10.50±2.20^**△△	10.60±2.20^**△△	2.893	13.517	70.542	0.059	<0.01	<0.01
BMI	33.13±3.45	34.20±4.67	34.51±5.81	42.88±6.10^**	47.17±8.25^**△△	48.57±0.59^**△△	4.433	12.116	77.520	0.014	<0.01	<0.01
TG c/(mmol·L^-1)	0.63±0.23	0.77±0.34	0.69±0.23	0.75±0.45	1.08±0.67^*△△	0.98±0.49^**△△	1.968	9.659	8.423	0.144	<0.01	0.040
TC c/(mmol·L^-1)	1.86±0.41	2.26±0.42^△△	2.09±0.52	2.07±0.44^**	2.47±0.55^△△	2.10±0.45	4.480	53.847	2.704	0.012	<0.01	0.103
LDL-C c/(mmol·L^-1)	0.97±0.25	0.84±0.27	0.81±0.30	0.96±0.29	0.95±0.36	0.88±0.31^*	1.902	6.624	1.271	0.151	<0.01	0.262
HDL-C c/(mmol·L^-1)	1.69±0.60	2.23±0.69^△△	2.29±0.69^△△	2.07±0.67	2.26±0.77^△	2.06±0.64	7.541	12.433	0.302	0.010	<0.01	0.584
FPG c/(mmol·L^-1)	4.40±0.24	4.52±1.12	4.49±1.58	4.48±1.04	5.25±1.99^△△	5.10±1.83^△△	1.826	3.442	3.524	0.163	0.034	0.063
HbA1c ω/%	4.12±1.34	4.11±0.29	4.10±0.25	4.21±0.19	4.42±0.92^△	4.45±1.45	0.606	0.437	3.502	0.547	0.642	0.064

组别 Group	患病 Disease	年龄/岁 Age/ years old	发病数/只（发病率/%） Number of cases (Incidence rate / %)
组别 Group	患病 Disease	年龄/岁 Age/ years old	2023	2024
正常组（N=30） Normal group	肥胖Obese	<8	0 (0.00)	0 (0.00)
		8~10	1 (8.33)	2 (33.33)
		11~13	2 (25.00)	3 (23.08)
		>13	2 (22.22)	2 (20.00)
		总计	5 (16.67)	7 (23.33)
	糖尿病Diabetes mellitus	<8	0 (0.00)	0 (0.00)
		8~10	2 (16.67)	1 (16.67)
		11~13	2 (25.00)	3 (23.08)
		>13	1 (11.11)	1 (10.00)
		总计	5 (16.67)	5 (16.67)
肥胖组（N=99） Obese group	肥胖Obese	<8	5 (100.00)	2 (100.00)
		8~10	15 (83.33)	10 (90.91)
		11~13	44 (100.00)	44 (100.00)
		>13	32 (100.00)	34 (100.00)
		总计	96 (96.97)	90 (90.91)
	糖尿病Diabetes mellitus	<8	0 (0.00)	0 (0.00)
		8~10	4 (22.23)	4 (33.33)
		11~13	16 (36.36)	21 (44.68)
		>13	9 (28.13)	19 (51.35)
		总计	29 (29.29)	44 (44.44)
	高脂血症Hyperlipidemia	8~10	1 (5.56)	1 (8.33)
	高脂血症Hyperlipidemia	总计	1 (1.01)	1 (1.01)

组别 Group	患病 Disease	年龄/岁 Age/ years old	发病数/只（发病率/%） Number of cases (Incidence rate / %)
组别 Group	患病 Disease	年龄/岁 Age/ years old	2023	2024
正常组（N=30） Normal group	肥胖Obese	<8	0 (0.00)	0 (0.00)
		8~10	1 (8.33)	2 (33.33)
		11~13	2 (25.00)	3 (23.08)
		>13	2 (22.22)	2 (20.00)
		总计	5 (16.67)	7 (23.33)
	糖尿病Diabetes mellitus	<8	0 (0.00)	0 (0.00)
		8~10	2 (16.67)	1 (16.67)
		11~13	2 (25.00)	3 (23.08)
		>13	1 (11.11)	1 (10.00)
		总计	5 (16.67)	5 (16.67)
肥胖组（N=99） Obese group	肥胖Obese	<8	5 (100.00)	2 (100.00)
		8~10	15 (83.33)	10 (90.91)
		11~13	44 (100.00)	44 (100.00)
		>13	32 (100.00)	34 (100.00)
		总计	96 (96.97)	90 (90.91)
	糖尿病Diabetes mellitus	<8	0 (0.00)	0 (0.00)
		8~10	4 (22.23)	4 (33.33)
		11~13	16 (36.36)	21 (44.68)
		>13	9 (28.13)	19 (51.35)
		总计	29 (29.29)	44 (44.44)
	高脂血症Hyperlipidemia	8~10	1 (5.56)	1 (8.33)
	高脂血症Hyperlipidemia	总计	1 (1.01)	1 (1.01)

指标 Indicator	年龄 Age	FPG	HbA1c	BW	AC	SFT	BMI	TG	TC	LDL-C	HDL-C
年龄Age	-	0.548^**	0.339	0.090	0.291	0.218	0.093	0.530^**	0.281	0.224	-0.079
FPG		-	0.819^**	0.492^*	0.481^*	0.338	0.463^*	0.565^**	-0.017	-0.003	-0.313
HbA1c			-	0.388	0.322	0.383	0.364	0.772^**	0.077	0.025	-0.359
BW				-	0.907^**	0.774^**	0.944^**	0.151	-0.427^*	-0.117	-0.458^*
AC					-	0.838^**	0.870^**	0.238	-0.386	-0.123	-0.472^*
SFT						-	0.745^**	0.389	-0.374	-0.222	-0.527^**
BMI							-	0.112	-0.418^*	-0.057	-0.461^*
TG								-	0.169	-0.002	-0.395
TC									-	0.713^**	0.681^**
LDL-C										-	0.291
HDL-C											-

肥胖食蟹猴一般身体指标、血糖、血脂的动态监测及相关性分析

Dynamic Monitoring and Correlation Analysis of General Body Indicators, Blood Glucose, and Blood Lipid in Obese Cynomolgus Monkeys

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

图/表 4

参考文献 17

相关文章 15

编辑推荐

Metrics

本文评价

[1]	杨劲, 俞诗雅, 林楠, 方永超, 赵虎, 邱锦维, 林鸿铭, 陈惠燕, 王瑜, 吴伟航. 改良型十二指肠旷置术对2型糖尿病大鼠糖代谢的影响[J]. 实验动物与比较医学, 2024, 44(5): 523-530.
[2]	卞新彦, 陆勇, 王燕, 孙强. 食蟹猴分娩行为分析[J]. 实验动物与比较医学, 2023, 43(4): 355-362.
[3]	梅承翰, 陈蓓蓓. 胰高血糖素样肽1类似物对阿尔兹海默症的神经保护作用及机制研究进展[J]. 实验动物与比较医学, 2023, 43(2): 186-193.
[4]	李晗, 张笑瑞, 张成芳. 间歇禁食法在改善奥氮平诱导小鼠代谢紊乱中的机制研究[J]. 实验动物与比较医学, 2023, 43(1): 3-10.
[5]	杨平, 崔立, 俞诚, 温智越. 贝伐珠单抗注射液对食蟹猴皮肤伤口愈合的影响[J]. 实验动物与比较医学, 2023, 43(1): 21-29.
[6]	韦祝梅, 申果, 李振明, 曾勇, 季风, 杨继红. 不同年龄段食蟹猴骨矿含量与骨密度测定分析[J]. 实验动物与比较医学, 2022, 42(5): 409-415.
[7]	吕晓君, 吴森, 张菊, 徐小玲, 潘望平, 李厚钢, 王平慧, 何开勇. 用高热量饲料建立大鼠肥胖模型的实验研究[J]. 实验动物与比较医学, 2020, 40(5): 374-.
[8]	高仕平, 李锋, 查思凡. 高脂饮食诱导的非酒精性脂肪肝病食蟹猴模型[J]. 实验动物与比较医学, 2020, 40(2): 123-127.
[9]	王成舟. 食蟹猴急性心肌梗死模型的建立及护理[J]. 实验动物与比较医学, 2019, 39(4): 314-318.
[10]	李良顺, 潘世友, 支元芳, 白帅州, 孙建华, 宫丽崑, 任进. 一例食蟹猴肠套叠诊断与治疗[J]. 实验动物与比较医学, 2019, 39(3): 236-238.
[11]	刘孟渊, 冯学轩, 黎莉斯, 张美艺. 胰岛素抵抗合并高尿酸血症大鼠模型的建立及其比较[J]. 实验动物与比较医学, 2019, 39(2): 99-104.
[12]	盛译萱, 曾国威, 姚亮亮, 李冰涛, 姜丽, 张启云, 徐国良. 肥胖大鼠的胰岛素抵抗指数与血脂的相关性观测[J]. 实验动物与比较医学, 2018, 38(6): 417-421.
[13]	黎砚书, 徐丽瑛, 周艳艳, 吴金花, 丁琦, 李艳, 李玉云, 肖小华. 栀子黄色素类单体对糖尿病小鼠降血糖作用[J]. 实验动物与比较医学, 2018, 38(5): 387-389.
[14]	韦毅, 符明泰, 阳明, 黄卫宣, 蓝娇, 覃喜军, 玉宁. 正常成年雄性食蟹猴部分免疫功能指标观测[J]. 实验动物与比较医学, 2018, 38(3): 236-238.
[15]	池骏, 龚慧, 何玥炜, 万颖寒, 费俭, 匡颖. 瘦素基因敲除小鼠模型的建立及表型分析[J]. 实验动物与比较医学, 2017, 37(5): 344-351.